3-63912684-GGCA-G
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP3BP6BS1BS2
The NM_001377405.1(ATXN7):c.116_118delAGC(p.Gln39del) variant causes a disruptive inframe deletion change. The variant allele was found at a frequency of 0.00328 in 1,078,090 control chromosomes in the GnomAD database, including 11 homozygotes. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.0059 ( 8 hom., cov: 23)
Exomes 𝑓: 0.0029 ( 3 hom. )
Consequence
ATXN7
NM_001377405.1 disruptive_inframe_deletion
NM_001377405.1 disruptive_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.60
Genes affected
ATXN7 (HGNC:10560): (ataxin 7) The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA types I-III. ADCAI is genetically heterogeneous, with five genetic loci, designated spinocerebellar ataxia (SCA) 1, 2, 3, 4 and 6, being assigned to five different chromosomes. ADCAII, which always presents with retinal degeneration (SCA7), and ADCAIII often referred to as the 'pure' cerebellar syndrome (SCA5), are most likely homogeneous disorders. Several SCA genes have been cloned and shown to contain CAG repeats in their coding regions. ADCA is caused by the expansion of the CAG repeats, producing an elongated polyglutamine tract in the corresponding protein. The expanded repeats are variable in size and unstable, usually increasing in size when transmitted to successive generations. This locus has been mapped to chromosome 3, and it has been determined that the diseased allele associated with spinocerebellar ataxia-7 contains 37-306 CAG repeats (near the N-terminus), compared to 4-35 in the normal allele. The encoded protein is a component of the SPT3/TAF9/GCN5 acetyltransferase (STAGA) and TBP-free TAF-containing (TFTC) chromatin remodeling complexes, and it thus plays a role in transcriptional regulation. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP3
Nonframeshift variant in repetitive region in NM_001377405.1
BP6
Variant 3-63912684-GGCA-G is Benign according to our data. Variant chr3-63912684-GGCA-G is described in ClinVar as [Benign]. Clinvar id is 1328067.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-63912684-GGCA-G is described in Lovd as [Benign]. Variant chr3-63912684-GGCA-G is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00589 (852/144714) while in subpopulation AFR AF= 0.0169 (676/39996). AF 95% confidence interval is 0.0158. There are 8 homozygotes in gnomad4. There are 410 alleles in male gnomad4 subpopulation. Median coverage is 23. This position pass quality control queck.
BS2
High AC in GnomAd4 at 852 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATXN7 | NM_001377405.1 | c.116_118delAGC | p.Gln39del | disruptive_inframe_deletion | 3/13 | ENST00000674280.1 | NP_001364334.1 | |
ATXN7 | NM_001177387.1 | c.116_118delAGC | p.Gln39del | disruptive_inframe_deletion | 2/13 | NP_001170858.1 | ||
ATXN7 | NM_000333.4 | c.116_118delAGC | p.Gln39del | disruptive_inframe_deletion | 3/13 | NP_000324.1 | ||
ATXN7 | NM_001377406.1 | c.116_118delAGC | p.Gln39del | disruptive_inframe_deletion | 2/12 | NP_001364335.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATXN7 | ENST00000674280.1 | c.116_118delAGC | p.Gln39del | disruptive_inframe_deletion | 3/13 | NM_001377405.1 | ENSP00000501377.1 |
Frequencies
GnomAD3 genomes AF: 0.00591 AC: 855AN: 144614Hom.: 9 Cov.: 23
GnomAD3 genomes
AF:
AC:
855
AN:
144614
Hom.:
Cov.:
23
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0230 AC: 238AN: 10356Hom.: 0 AF XY: 0.0254 AC XY: 141AN XY: 5542
GnomAD3 exomes
AF:
AC:
238
AN:
10356
Hom.:
AF XY:
AC XY:
141
AN XY:
5542
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00288 AC: 2689AN: 933376Hom.: 3 AF XY: 0.00318 AC XY: 1406AN XY: 441998
GnomAD4 exome
AF:
AC:
2689
AN:
933376
Hom.:
AF XY:
AC XY:
1406
AN XY:
441998
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00589 AC: 852AN: 144714Hom.: 8 Cov.: 23 AF XY: 0.00582 AC XY: 410AN XY: 70408
GnomAD4 genome
AF:
AC:
852
AN:
144714
Hom.:
Cov.:
23
AF XY:
AC XY:
410
AN XY:
70408
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at